Beta
Company data is growing.
← All companies
/
Top lists
/
Boston Scientific
Boston Scientific
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
9 076
9 048
9 823
10 735
9 913
11 888
12 682
14 240
16 747
20 074
Operating profit (EBIT)
447
1 285
1 506
1 518
−80
1 199
1 649
2 343
2 603
3 613
Net income attributable to shareholders
347
104
1 671
4 700
−115
985
642
1 570
1 853
2 898
EBIT margin
4,9%
14,2%
15,3%
14,1%
−0,8%
10,1%
13,0%
16,5%
15,5%
18,0%
Gross margin
65,7%
71,3%
71,4%
71,0%
65,1%
68,8%
68,8%
69,5%
68,6%
69,0%
Operating cash flow
972
1 426
310
1 836
1 508
1 870
1 526
2 503
3 435
4 534
Free cash flow
596
1 107
−6
1 375
1 132
1 316
938
1 792
2 645
3 658
Cash
196
188
146
217
1 734
1 925
928
865
414
1 965
−5 000
0
5 000
10 000
15 000
20 000
25 000
−5,0%
0,0%
5,0%
10,0%
15,0%
20,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
9 076
9 048
9 823
10 735
9 913
11 888
12 682
14 240
16 747
20 074
447
1 285
1 506
1 518
−80
1 199
1 649
2 343
2 603
3 613